NanoViricides Inc. (NNVC)

[changes_iv]

Phase I and Phase II of GLP toxicology studies conducted by BASi do not contradict KARD Scientific, Inc. non-GLP findings.

Wednesday, 12/10/14 --- Those that proposed that the Doctor's recent purchase of 50,000 shares stood as a symbol of his confidence in the company now need to consider what his sale of a multiple of that amount might mean. Seriously, I think his recent purchase was meant to mitigate against any questions that these sales might raise. ~ loanranger

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108956514
The Pilot Plant was commissioned sometime on Jan 2015 to produce FluCide(TM)/GLP and we are making FluCide(TM)drug product/GLP for the final Phase III of toxicology studies.

June 1, 2015, 9:47 PM

FluCide

Phase I and II of tox successfully completed

Making material for last Phase in large animals

MersCide

Waiting for Public Health England to request the drug (sitting on the shelf) for testing. They got distracted by the Ebola outbreak

EbolaCide

Making more drug for continuation of the testing by USAMRIID

Had FluCide not turned out to be so incredibly safe, we would have been done with tox by now. Incredibly safe is not a bad thing at all!

Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
[e-mail]
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange

In my view, Dr. Milton Boniuk knows we were successful producing identical batches of FluCide(TM)/GLP during the first half of year 2015 and now we are making the 2Kg of FluCide(TM) for BASi final Phase III of toxicology studies hence, he buys!
http://ih.advfn.com/p.php?pid=nmona&article=67659713
http://ih.advfn.com/p.php?pid=nmona&article=67464536

Unlike you, an anonymous poster, he is an insider, he knows and buys with confidence.